Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Rubenstein

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Brain Pathology (Zurich, Switzerland)|December 19, 2014
77-year-old woman with a dural-based mass. Marginal zone B-cell lymphoma (MZBCL)Ross A Okimoto, Arie Perry, James L Rubenstein
British Journal of Haematology|May 20, 2014
Progress in central nervous system lymphomasChia-Ching Wang, Julia Carnevale, James L Rubenstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Biology and treatment of primary central nervous system lymphomaAlain P Algazi, Cigall Kadoch, James L Rubenstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapyJames L Rubenstein, Patrick A Treseler, Paul J Stewart
Current Oncology Reports|December 17, 2008
Insights into the biology of primary central nervous system lymphomaMaciej M Mrugala, James L Rubenstein, Maurilio Ponzoni, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Evolving Treatments for Primary Central Nervous System LymphomaAndrés J M Ferreri, Matthias Holdhoff, Lakshmi Nayak, et al.
British Journal of Haematology|February 5, 2019
Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphomaKhoan Vu, Gabriel Mannis, Jimmy Hwang, et al.
Ejhaem|September 2, 2022
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case reportVanshika Goyal, Giselle Salmasi, Andrew D Leavitt, et al.
Ocular Oncology and Pathology|January 25, 2019
Insights from a Case of Vitreoretinal LymphomaBertil E Damato, Gregory J Bever, Armin R Afshar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Reply to M.C. ChamberlainJames L Rubenstein, Bruce D Cheson, Sin-Ho Jung, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Brain Pathology (Zurich, Switzerland)|December 19, 2014
77-year-old woman with a dural-based mass. Marginal zone B-cell lymphoma (MZBCL)Ross A Okimoto, Arie Perry, James L Rubenstein
British Journal of Haematology|May 20, 2014
Progress in central nervous system lymphomasChia-Ching Wang, Julia Carnevale, James L Rubenstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Biology and treatment of primary central nervous system lymphomaAlain P Algazi, Cigall Kadoch, James L Rubenstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapyJames L Rubenstein, Patrick A Treseler, Paul J Stewart
Current Oncology Reports|December 17, 2008
Insights into the biology of primary central nervous system lymphomaMaciej M Mrugala, James L Rubenstein, Maurilio Ponzoni, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Evolving Treatments for Primary Central Nervous System LymphomaAndrés J M Ferreri, Matthias Holdhoff, Lakshmi Nayak, et al.
British Journal of Haematology|February 5, 2019
Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphomaKhoan Vu, Gabriel Mannis, Jimmy Hwang, et al.
Ejhaem|September 2, 2022
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case reportVanshika Goyal, Giselle Salmasi, Andrew D Leavitt, et al.
Ocular Oncology and Pathology|January 25, 2019
Insights from a Case of Vitreoretinal LymphomaBertil E Damato, Gregory J Bever, Armin R Afshar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Reply to M.C. ChamberlainJames L Rubenstein, Bruce D Cheson, Sin-Ho Jung, et al.
Pageof 6